Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

CytoSorbents Enrolls First Patient into Pivotal U.S. REFRESH 2-AKI Trial Using CytoSorb® During Complex Cardiac Surgery

CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy company using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced first patient enrollment into the pivotal U.S. REFRESH 2-AKI trial.

Metabolically healthy obesity often a ‘transient state’ on slide to CVD

Metabolically healthy obesity (MHO) is not a stable state—rather, it's a slippery slope toward metabolic syndrome and increased risk of cardiovascular disease (CVD), suggests a long-term study published April 23 in the Journal of the American College of Cardiology.

Thumbnail

Menopause-related mitochondrial dysfunction ups CVD risk in older women

Researchers have identified what they believe is a molecular explanation for why cardiovascular disease (CVD) occurs later in women than in men.

Thumbnail

Nicorandil protects older patients from myocardial injury after PCI

Intravenous nicorandil cut the risk of periprocedural myocardial injury (pMI) after percutaneous coronary intervention (PCI) by 49 percent among patients 65 and older, according to a substudy of a randomized trial published in PLOS One.

Thumbnail

Medtronic DCB approved to treat longer lesions

Medtronic’s IN.PACT Admiral drug-coated balloon (DCB) has received an expanded indication from the FDA and is now cleared to treat long superficial femoral artery lesions up to 360 millimeters, the company announced April 23.

Nearly half of on-duty firefighter deaths are cardiac

About 47 percent of on-duty firefighter deaths are heart-related, according to the U.S. Fire Administration (USFA).

Thumbnail

Slow walking speed signals future hospitalizations for heart patients

Heart disease patients who are slow walkers are at a higher risk of hospitalization than their speedier counterparts, according to research presented April 20 at EuroPrevent 2018.

Mitochondrial antioxidant may reverse vascular aging

An antioxidant that targets cellular mitochondria appeared to reverse age-related vascular changes by 15 to 20 years in older adults, according to a small, first-in-human study published April 16 in Hypertension.